Screening for primary open-angle glaucoma in the developed world: Are we there yet?

Canadian Journal of Ophthalmology

Volumn 40, Issue 4, 2005, Pages 477-486

  Harasymowycz, Paul ^a   Fansi, Alvine Kamdeu ^a   Papamatheakis, Demosthenes ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

AETMIS; Glaucoma; POAG; Screening

Indexed keywords

PROSTAGLANDIN DERIVATIVE;

COMPUTER ASSISTED PERIMETRY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HEALTH CARE POLICY; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; OPHTHALMOLOGY; OPTIC NERVE LESION; OPTICAL COHERENCE TOMOGRAPHY; PACHOMETRY; POLARIMETRY; PSYCHOPHYSICS; REVIEW; RISK FACTOR; SCANNING LASER OPHTHALMOSCOPY; SCREENING; TRABECULOPLASTY; VISION TEST;

EID: 24044488652     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(05)80010-9     Document Type: Article

References (84)

1. Conseil d'evaluation des technologies de la santé du Québec (CETSQ). Le dépistage du glaucome primitif à angle ouvert. Montréal, Qué.: CETSQ 1995. Available: http:// www.aetmis.gouv.qc.ca/fr/publications/scientifiques/depistag e/1995_29_en.pdf (accessed 2004 Nov 8)
2. Tuck MW, Crick RP. The projected increase in glaucoma due to an ageing population. Ophthalmic Physiol Opt 2003;23: 175-9.
3. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci 1997;38:83-91.
4. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal prevalence of major eye diseases. Arch Ophthalmol 2003;121:1303-10.
5. Wilson JMG, Jungner G. Principes et Pratique du Dépistage des Maladies. Cahiers de Santé publique No 34. ISBN: 92 4 230034 9. Geneva, Switzerland: World Health Organization, 1970. Available: http://www.who.int (accessed 2004 Nov 8)
6. Mains V. CNIB client statistics 1995. Canadian National Institute for the Blind website. Available: www.cnib.ca (accessed 2004 Nov 8)
7. Patterson C. Screening for visual impairment in the elderly. In: Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Ottawa, Ont.: Health Canada Cat H21-117/1994E; 1994: 932-42. Available: http://www.hc-sc.gc.ca/hppb/healthcare/ pdf/ clinical_preventive/s11c78e.pdf (accessed 2004 Nov 8)
8. Quigley HA. Open-angle glaucoma. N Engl J Med 1993; 328:1097-1106.
9. Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999;106:2144-53.
10. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
11. Tuck MW, Crick RP. The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol 1998;5:173-83.
12. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia - The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-9.
13. Ramrattan RS, Wolfs RC, Panda-Jonas S, et al. Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study, [published erratum appears in Arch Ophthalmol 2002; 120:525] Arch Ophthalmol 2001;119:1788-94.
14. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002;295:1077-9.
15. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
16. American Academy of Ophthalmology Preferred Practice Pattern Committee Glaucoma Panel. Primary Open-Angle Glaucoma, Limited Revision. 2003. Available: http:// www.aao.org/aao/education/library/ppp/upload/Primary-Open-Angle- Glaucoma.pdf (accessed 2004 Nov 8)
17. Vernon SA. Intra-eye pressure range and pulse profiles in normals with the pulsair non-contact tonometer. Eye 1993; 7:134-7.
18. Jackson C, Bullock J, Pitt M, Keogh J, Glasson W, Hirst L. Screening for glaucoma in a Brisbane general practice-the role of tonometry. Aust NZ J Ophthalmol 1995;23:173-8.
19. Faucher A, Gregoire J, Blondeau P. Accuracy of Goldmann tonometry after refractive surgery. J Cataract Refract Surg 1997;23:832-8.
20. Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Opthalmol 2003;136:805-13.
21. Burvenich H, De Clercq J. The combined IOP and CCT measurement in glaucoma screening. Bull Soc Belge Ophtalmol 2000;276:15-18.
22. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 2000;41:741-8.
23. Quaranta GM, Vetrugno M, Trabucco T, Cantatore F, Cardia L. The role of frequency doubling technology (FDT) in glaucoma screening. Acta Ophthalmol Scand 2000;78(suppl 232): 21-3
24. Medeiros FA, Sample PA, Weinreb RN. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol 2004;137:863-71.
25. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 1988;95:357-63.
26. Yamada N, Chen PP, Mills RP, et al. Screening for glaucoma with frequency-doubling technology and Damato campimetry. Arch Ophthalmol 1999;117:1479-84.
27. Tribble JR, Schultz RO, Robinson JC, Rome TL. Accuracy of glaucoma detection with frequency-doubling perimetry. Am J Ophthalmol 2000;129:740-5.
28. Thomas R, Bhat S, Muliyil JP, Parikh R, George R. Frequency doubling perimetry in glaucoma. J Glaucoma 2002;11: 46-50.
29. Tatemichi M, Nakano T, Tanaka K, et al. Laterality of the performance of glaucoma mass screening using frequency-doubling technology. J Glaucoma 2003;12:221-5.
30. Sponsel WE, Arango S, Trigo Y, Mensah J. Clinical classification of glaucomatous visual field loss by frequency doubling perimetry. Am J Ophthalmol 1998;125:830-6.
31. Soliman MAE, De Jong LAMS, Ismaeil A, Van den Berg TJTP, De Smet MD. Standard achromatic perimetry, short wavelength automated perimetry, and frequency doubling technology for detection of glaucoma damage. Ophthalmology 2002;109:444-54.
32. Maeda H, Tanaka Y, Nakamura M, Yamamoto M. Blue-on-yellow perimetry using an Armaly glaucoma screening program. Ophthalmologica 1999;213:71-5.
33. Chia WL, Goldberg I, Bauman A. Can the current oculokinetic perimetry chart be improved? Aust NZ J Ophthalmol 1999;27:312-7.
34. Chia WL, Goldberg I, Bauman A. Evaluation of oculokinetic perimetry. Aust NZJ Ophthalmol 1999;27:306-11.
35. Christoffersen T, Fors T, Waage S, Holtedahl K. Glaucoma screening with oculokinetic perimetry in general practice: is its specificity acceptable? Eye 1995;9:36-9.
36. Hatch WV, Flanagan JG, Williams-Lyn DE, Buys YM, Farra T, Trope GE. Interobserver agreement of Heidelberg retina tomograph parameters. J Glaucoma 1999;8:232-7.
37. Ervin JC, Lemij HG, Mills RP, Quigley HA, Thompson HW, Burgoyne CF. Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study. Ophthalmology 2002;109:467-81.
38. Chauhan BC, McCormick TA, Nicolela MT, LeBlanc RP. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol 2001;119:1492-9.
39. Wollstein G, Garway-Heath DF, Hitchings RA. Identification of early glaucoma cases with the scanning laser ophthalmoscope. Ophthalmology 1998;105:1559-63.
40. Kamal DS, Viswanathan AC, Garway-Heath DF, Hitchings RA, Poinoosawmy D, Bunce C. Detection of optic disc change with the Heidelberg retina tomograph before confirmed visual field change in ocular hypertensives converting to early glaucoma. Br J Ophthalmol 1999;83:290-4.
41. Caprioli J, Park HJ, Ugurlu S, Hoffman D. Slope of the peripapillary nerve fiber layer surface in glaucoma. Invest Ophthalmol Vis Sci 1998;39:2321-8.
42. Bathija R, Zangwill L, Berry CC, Sample PA, Weinreb RN. Detection of early glaucomatous structural damage with confocal scanning laser tomography. J Glaucoma 1998;7:121-7.
43. Sanchez-Galeana C, Bowl C, Blumenthal EZ, Gokhale PA, Zangwill LM, Weinreb RN. Using optical imaging data to detect glaucoma. Ophthalmology 2001;108:1812-8.
44. Bowd C, Weinreb RN, Williams JM, Zangwill LM. The retinal nerve fiber layer thickness in ocular-hypertensive, normal and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol 2000;118:22-6.
45. Schuman JS, Hee MR, Arya AV, et al. Optical coherence tomography: a new tool for glaucoma diagnosis. Curr Opin Ophthalmol 1995;6:89-95.
46. Hrynchak P, Simpson T. Optical coherence tomography: an introduction to the technique and its use. Optom Vis Sci 2000:77:347-56.
47. Kee C, Cho C. Evaluation of retinal nerve fiber layer thickness in the area of apparently normal hemifield in glaucomatous eyes with optical coherence tomography. J Glaucoma 2003;12:250-4.
48. Essock EA, Sinai MJ, Bowd C, Zangwill LM, Weinreb RN. Fourier analysis of optical coherence tomography and scanning laser polarimetry retinal nerve fiber layer measurements in the diagnosis of glaucoma. Arch Ophthalmol 2003;121: 1238-45.
49. Yamada N, Chen PP, Mills RP, et al. Glaucoma screening using the scanning laser polarimeter. J Glaucoma 2000;9: 254-61.
50. Choplin NT, Lundy DC. The sensitivity and specificity of scanning laser polarimetry in the detection of glaucoma in a clinical setting. Ophthalmology 2001;108:899-904.
51. Weinreb RN, Zangwill L, Berry CC, Bathija R, Sample PA. Detection of glaucoma with laser polarimetry. Arch Ophthalmol 1998;116:1583-9.
52. Reus NJ, Lemij HG. Diagnostic accuracy of the GDx VCC for glaucoma. Ophthalmology 2004;111:1860-5.
53. Wang F, Quigley HA, Tielsch JM. Screening for glaucoma in a medical clinic with photographs of the nerve fiber layer. Arch Ophthalmol 1994;112:796-800.
54. Bowd C, Zangwill LM, Berry C, et al. Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci 2001;42: 1993-2003.
55. Ntim-Amponsah CT. Intraocular pressure asymmetry-Topcon Computerized Tonometer CT-20. West Afr J Med 1997;16:191-4.
56. Swindale NV, Stjepanovic G, Chin A, Mikelberg F. Automated analysis of normal and glaucomatous optic nerve head topography images. Invest Ophthalmol Vis Sci 2000;41: 1730-42.
57. Tuulonen A, Ohinmaa A, Alanko HI, Hyytinen P, Juutinen A, Toppinen E. The application of teleophthalmology in examining patients with glaucoma: a pilot study. J Glaucoma 1999;8:367-373.
58. Li HK, Tang RA, Oschner K, Koplos C, Grady J, Crump WJ. Telemedicine screening of glaucoma. Telemed J 1999;5: 283-90.
59. Yogesan K, Constable IJ, Barry CJ, et al. Evaluation of portable fundus camera for use in the teleophthalmologic diagnosis of glaucoma. J Glaucoma 1999;8:297-301.
60. Yogesan K, Constable IJ, Eikelboom RH, van Saarloos PP. Tele-ophthalmic screening using digital imaging devices. Aust NZJ Ophthalmol 1998;26(suppl 1):S9-S11.
61. Harper RA, Reeves BC. Glaucoma screening: the importance of combining test data. Optom Vis Sci 1999;76:537-43.
62. Michelson G, Groh MJ. Screening models for glaucoma. Curr Opin Ophthalmol 2001;12:105-11.
63. Power EJ, Wagner JL, Duffy BM. Screening for Open-Angle Glaucoma in the Elderly. Washington, D.C.: Office of Technology Assessment (OTA); Oct. 1988. Available: http://www.wws.princeton.edu/~ota/disk2/1988/8836_n.ht ml (accessed 2004 Nov 8)
64. Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79.
65. Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108:1943-53.
66. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-97.
67. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-40.
68. Janz NK, Wren PA, Lichter PR, et al. CIGTS Study Group. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 2001;108:1954-65.
69. Mills RP, Janz NK, Wren PA, Guire KE. Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glaucoma 2001;10:192-8.
70. Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE. Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2001;108:887-97.
71. Mills RP. Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. Trans Am Ophthalmol Soc 1998;96:753-812.
72. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997;115:777-84.
73. Reardon G, Schwanz GF, Mozaffari E. Patient persistency with pharmacotherapy in the management of glaucoma. Eur J Ophthalmol 2003;13(suppl 4):S44-S52.
74. Strutton DR, Walt JG. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma 2004;13:221-6.
75. Damji KF, Shah KC, Rock WJ, Bains HS, Hodge WG. Selective laser trabeculoplasty v. argon laser trabeculoplasty: a prospective randomized clinical trial. Br J Ophthalmol 1999; 83:718-22.
76. Hennekens C, Buring J. Screening. In: Mayrent S, ed. Epidemiology in Medicine. Boston, Mass: Little, Brown and Co.; 1987:327-347.
77. Quigley HA. Current and future approaches to glaucoma screening. J Glaucoma 1998;7:210-20.
78. Niessen AG, Langerhorst CT, Geijssen HC, Greve EL. Design of low cost glaucoma screening. Doc Ophthalmol 1997;93:293-315.
79. Tuck WM, Crick RP. The cost-effectiveness of various modes of screening for primary open angle glaucoma. Ophthalmic Epidemiology 1997;4:3-17.
80. Canadian Task Force on the Periodic Health Examination. Periodic Health Examination, 1995 update: 3. Screening for visual problems among elderly patients. Can Med Assoc J 1995;152:1211-22.
81. Statistics Canada. The 2001 Census. A profile of the Canadian population by age and sex: Canada ages. Available: http:// www12.statcan.ca/english/ census01/Products/Analytic/ companion/age/contents.cfm (accessed 2004 Nov 8)
82. Jackson C, Hirst L. Brisbane GPs' perceptions of screening for primary open-angle glaucoma. Aust NZ J Ophthalmol 1995; 23:179-81.
83. Gilchrist J. Optometric glaucoma referrals - measures of effectiveness and implications for screening strategy. Ophthalmic Physiol Opt 2000;20:452-63.
84. Vernon SA, Ghosh G. Do locally agreed guidelines for optometrists concerning the referral of glaucoma suspects influence referral practice? Eye 2001;15:458-63.